Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    22643560 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Bevacizumab;   Drug: Erlotinib

Study has passed its completion date and status has not been verified in more than two years.